News
A CU Boulder research team co-led by Distinguished Professor Christopher Bowman has received up to $5.8 million from ARPA-H to develop new treatments that temporarily suspend the immune response after severe burns or tissue injuries, aiming to reduce pain, speed healing and prevent long-term damage. The approach could also benefit patients with limited access to immediate medical care.
SPUR student Joshua Smith joined researchers in the Shields Lab to develop microrobots that actively deliver drugs to the lungs—an innovative approach that could transform treatment for acute respiratory distress syndrome.
Saad Bhamla, a pioneering scientist known for studying unusual biological systems and inventing ultra-low-cost medical devices, will join the Department of Chemical and Biological Engineering and the BioFrontiers Institute in August. His work blends biology, engineering and frugal science.
CU Boulder’s chemical engineering program retained its No. 11 spot among public engineering programs in the U.S., according to U.S. News & World Report. ChBE's biological engineering program was not ranked, likely due to the program’s newness and the field’s typical association with agricultural programs in USN&WR.
Ankur Gupta named ecipient ofRoyal Society of Chemistry's 2025 Soft Matter Lectureship, a award recognizing outstanding early-career researchers in the field.
Distinguished Professor Kristi Anseth, also the associate faculty director of CU Boulder’s BioFrontiers Institute, designs biomaterials that interact with living tissues to promote repair and regeneration, aiding in healing injuries and diseases. Her lab works with hydrogels—a degradable biomaterial—to deliver molecules at the right time and sequence to accelerate the healing process.
CU Boulder Chemical and Biological Engineering building community around electrochemistry and energy innovation.
CU Boulder researchers, led by Professor Ted Randolph, have developed a groundbreaking temperature-stable rabies vaccine that combines multiple doses into a single shot—an innovation that could vastly improve global access to life-saving immunization.
Professor Kristi Anseth is known for developing tissue substitutes that improve treatments for conditions like broken bones and heart valve disease. She recently made key discoveries about sex-based differences in cardiac treatment outcomes. Anseth is also among the few innovators elected to all three national academies: Sciences, Engineering and Medicine.
See is advancing new technologies to boost the performance of future sustainable batteries.